SCHEMBL30761548

SCHEMBL30761548

Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCN(C2CCNCC2)CC1

nearest known ligand 0.87

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALK Q9UM73 20/20 0.87
▸ INSR P06213 13/20 0.87
▸ KCNH2 Q12809 4/20 0.87
▸ PLK4 O00444 1/20 0.87
▸ BUB1B O60566 1/20 0.87
▸ JAK2 O60674 1/20 0.87
▸ ROCK2 O75116 1/20 0.87
▸ ABL1 P00519 1/20 0.87
▸ EGFR P00533 1/20 0.87
▸ NTRK1 P04629 1/20 0.87
▸ LCK P06239 1/20 0.87
▸ NPM1 P06748 1/20 0.87
▸ FES P07332 1/20 0.87
▸ LYN P07948 1/20 0.87
▸ RET P07949 1/20 0.87
▸ IGF1R P08069 1/20 0.87
▸ ABCB1 P08183 1/20 0.87
▸ MET P08581 1/20 0.87
▸ ROS1 P08922 1/20 0.87
▸ FGR P09769 1/20 0.87

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28619135 1.00 ALK (0.87) ALKINSRKCNH2PLK4BUB1B
SCHEMBL30761263 0.95 ALK (0.81) ALKINSRKCNH2PLK4BUB1B
SCHEMBL28619123 0.94 ALK (0.87) ALKINSRKCNH2PLK4BUB1B
SCHEMBL28619149 0.94 ALK (0.85) ALKINSRKCNH2PLK4BUB1B
SCHEMBL30761470 0.94 ALK (0.85) ALKINSRKCNH2PLK4BUB1B
Hydrochloric Acid SCHEMBL30761495 0.93 ALK (0.84) ALKINSRKCNH2PLK4BUB1B
Ceritinib SCHEMBL1014329 0.93 ALK (1.00) ALKINSRKCNH2PLK4BUB1B
Ceritinib SCHEMBL29349781 0.93 ALK (1.00) ALKINSRKCNH2PLK4BUB1B
Ceritinib SCHEMBL29489147 0.93 ALK (1.00) ALKINSRKCNH2PLK4BUB1B
SCHEMBL1545914 0.93 ALK (1.00) ALKINSRKCNH2PLK4BUB1B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024059525-A2 COMPOUNDS AND METHODS FOR THE TARGETED DEGRADATION OF ANAPLASTIC LYMPHOMA KINASE AND ROS1 KINASE ENDOTARGET, INC. (US) 2024-03-21 — — WO disclosed
Send feedback